<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37340634</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-0024</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>06</Day></PubDate></JournalIssue><Title>Molecular therapy : the journal of the American Society of Gene Therapy</Title><ISOAbbreviation>Mol Ther</ISOAbbreviation></Journal><ArticleTitle>Preventing occludin tight-junction disruption via inhibition of microRNA-193b-5p attenuates viral load and influenza-induced lung injury.</ArticleTitle><Pagination><StartPage>2681</StartPage><EndPage>2701</EndPage><MedlinePgn>2681-2701</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ymthe.2023.06.011</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1525-0016(23)00322-2</ELocationID><Abstract><AbstractText>Virus-induced lung injury is associated with loss of pulmonary epithelial-endothelial tight junction integrity. While the alveolar-capillary membrane may be an indirect target of injury, viruses may interact directly and/or indirectly with miRs to augment their replication potential and evade the host antiviral defense system. Here, we expose how the influenza virus (H1N1) capitalizes on host-derived interferon-induced, microRNA (miR)-193b-5p to target occludin and compromise antiviral defenses. Lung biopsies from patients infected with H1N1 revealed increased miR-193b-5p levels, marked reduction in occludin protein, and disruption of the alveolar-capillary barrier. In C57BL/6 mice, the expression of miR-193b-5p increased, and occludin decreased, 5-6 days post-infection with influenza (PR8). Inhibition of miR-193b-5p in primary human bronchial, pulmonary microvascular, and nasal epithelial cells enhanced antiviral responses. miR-193b-deficient mice were resistant to PR8. Knockdown of occludin, both in vitro and in vivo, and overexpression of miR-193b-5p reconstituted susceptibility to viral infection. miR-193b-5p inhibitor mitigated loss of occludin, improved viral clearance, reduced lung edema, and augmented survival in infected mice. Our results elucidate how the innate immune system may be exploited by the influenza virus and how strategies that prevent loss of occludin and preserve tight junction function may limit susceptibility to virus-induced lung injury.</AbstractText><CopyrightInformation>Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vaswani</LastName><ForeName>Chirag M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Physiology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varkouhi</LastName><ForeName>Amir K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Environmental Science, New Jersey Institute of Technology, Newark, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Sahil</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada; Institute of Medical Sciences, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Faculty of Medicine, School of Medicine, The University of Queensland, Herston, QLD 4006, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ektesabi</LastName><ForeName>Amin M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada; Institute of Medical Sciences, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsoporis</LastName><ForeName>James N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yousef</LastName><ForeName>Sadiya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plant</LastName><ForeName>Pamela J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Adriana L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; COVID-19 Virus Network from Ministry of Science, Technology, and Innovation, Brazilian Council for Scientific and Technological Development, and Foundation Carlos Chagas Filho Research Support of the State of Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cen</LastName><ForeName>Yuchen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Program in Translational Medicine, SickKids Research Institute, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tseng</LastName><ForeName>Yi-Chieh</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Program in Translational Medicine, SickKids Research Institute, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batah</LastName><ForeName>Sabrina S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fabro</LastName><ForeName>Alexandre T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Advani</LastName><ForeName>Suzanne L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Advani</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leong-Poi</LastName><ForeName>Howard</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada; Institute of Medical Sciences, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marshall</LastName><ForeName>John C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada; Institute of Medical Sciences, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Cristiana C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Laboratory of Respiratory, Exanthematic Viruses, Enterovirus and Viral Emergencies, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil; Integrated Research Group on Biomarkers. René Rachou Institute, FIOCRUZ Minas, Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rocco</LastName><ForeName>Patricia R M</ForeName><Initials>PRM</Initials><AffiliationInfo><Affiliation>Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; COVID-19 Virus Network from Ministry of Science, Technology, and Innovation, Brazilian Council for Scientific and Technological Development, and Foundation Carlos Chagas Filho Research Support of the State of Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albaiceta</LastName><ForeName>Guillermo M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Departamento de Biología Funcional, Instituto Universitario de Oncología del Principado de Asturias, Universidad de Oviedo, Oviedo, Spain; Unidad de Cuidados Intensivos Cardiológicos, Hospital Universitario Central de Asturias, Oviedo, Spain; CIBER-Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sebastian-Bolz</LastName><ForeName>Steffen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physiology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watts</LastName><ForeName>Tania H</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Department of Immunology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moraes</LastName><ForeName>Theo J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Program in Translational Medicine, SickKids Research Institute, Toronto, ON, Canada; Department of Pediatrics University of Toronto and Respirology, Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capelozzi</LastName><ForeName>Vera L</ForeName><Initials>VL</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of São Paulo, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dos Santos</LastName><ForeName>Claudia C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Physiology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada; Institute of Medical Sciences, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Interdepartmental Division of Critical Care, St Michael's Hospital, University of Toronto, Toronto, ON, Canada. Electronic address: claudia.dossantos@unityhealth.to.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Ther</MedlineTA><NlmUniqueID>100890581</NlmUniqueID><ISSNLinking>1525-0016</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062793">Occludin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062793" MajorTopicYN="N">Occludin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055370" MajorTopicYN="Y">Lung Injury</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019108" MajorTopicYN="N">Tight Junctions</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="Y">Influenza A Virus, H1N1 Subtype</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute lung injury</Keyword><Keyword MajorTopicYN="N">acute respiratory distress syndrome</Keyword><Keyword MajorTopicYN="N">alveolar-capillary membrane</Keyword><Keyword MajorTopicYN="N">antiviral immune response</Keyword><Keyword MajorTopicYN="N">influenza virus</Keyword><Keyword MajorTopicYN="N">interferon beta</Keyword><Keyword MajorTopicYN="N">miR-193b</Keyword><Keyword MajorTopicYN="N">microRNA</Keyword><Keyword MajorTopicYN="N">occludin</Keyword><Keyword MajorTopicYN="N">tight junctions</Keyword></KeywordList><CoiStatement>Declaration of interests The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>21</Day><Hour>1</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37340634</ArticleId><ArticleId IdType="pmc">PMC10491994</ArticleId><ArticleId IdType="doi">10.1016/j.ymthe.2023.06.011</ArticleId><ArticleId IdType="pii">S1525-0016(23)00322-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Luyt C.E., Combes A., Trouillet J.L., Nieszkowska A., Chastre J. Virus-induced acute respiratory distress syndrome: Epidemiology, management and outcome. Press. Medicale. 2011;40:e561–e568. doi: 10.1016/j.lpm.2011.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lpm.2011.05.027</ArticleId><ArticleId IdType="pmc">PMC7125714</ArticleId><ArticleId IdType="pubmed">22094172</ArticleId></ArticleIdList></Reference><Reference><Citation>Taubenberger J.K., Kash J.C., Morens D.M. The 1918 influenza pandemic: 100 years of questions answered and unanswered. Sci. Transl. Med. 2019;11 doi: 10.1126/scitranslmed.aau5485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aau5485</ArticleId><ArticleId IdType="pmc">PMC11000447</ArticleId><ArticleId IdType="pubmed">31341062</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawood F.S., Iuliano A.D., Reed C., Meltzer M.I., Shay D.K., Cheng P.Y., Bandaranayake D., Breiman R.F., Brooks W.A., Buchy P., et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: A modelling study. Lancet Infect. Dis. 2012;12:687–695. doi: 10.1016/S1473-3099(12)70121-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(12)70121-4</ArticleId><ArticleId IdType="pubmed">22738893</ArticleId></ArticleIdList></Reference><Reference><Citation>Short K.R., Kroeze E.J.B.V., Fouchier R.A.M., Kuiken T. Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect. Dis. 2014;14:57–69. doi: 10.1016/S1473-3099(13)70286-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70286-X</ArticleId><ArticleId IdType="pubmed">24239327</ArticleId></ArticleIdList></Reference><Reference><Citation>Karginov F.V., Hannon G.J., Thaler J.P., Tschöp M.H., Michael W., Thaler J.P., Yi C., Schur E.A., Guyenet S.J., Hwang B.H., et al. Receptor binding and pH stability - How influenza A virus hemagglutinin affects host-specific virus infection. J. Virol. 2015;7:1–7. doi: 10.1016/j.lpm.2011.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lpm.2011.05.027</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos C.L., Moraes L., Santos R.S., dos Santos Samary C., Silva J.D., Morales M.M., Capelozzi V.L., de Abreu M.G., Schanaider A., Silva P.L., et al. The biological effects of higher and lower positive end-expiratory pressure in pulmonary and extrapulmonary acute lung injury with intra-abdominal hypertension. Crit. Care. 2014;18:1211–R211. doi: 10.1186/cc13920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13920</ArticleId><ArticleId IdType="pmc">PMC4095606</ArticleId><ArticleId IdType="pubmed">24928415</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauad T., Hajjar L.A., Callegari G.D., Da Silva L.F.F., Schout D., Galas F.R.B.G., Alves V.A.F., Malheiros D.M.A.C., Auler J.O.C., Ferreira A.F., et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am. J. Respir. Crit. Care Med. 2010;181:72–79. doi: 10.1164/rccm.200909-1420OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200909-1420OC</ArticleId><ArticleId IdType="pubmed">19875682</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong S.M., Wang C., Tigdi J., Si X., Dumpit C., Charles S., Gamage A., Moraes T.J., Lee W.L. Influenza Infects Lung Microvascular Endothelium Leading to Microvascular Leak: Role of Apoptosis and Claudin-5. PLoS One. 2012;7:e47323. doi: 10.1371/journal.pone.0047323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0047323</ArticleId><ArticleId IdType="pmc">PMC3480371</ArticleId><ArticleId IdType="pubmed">23115643</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson J.M., Van Itallie C.M., Peterson M.D., Stevenson B.R., Carew E.A., Mooseker M.S. ZO-1 mRNA and protein expression during tight junction assembly in Caco-2 cells. J. Cell Biol. 1989;109:1047–1056. doi: 10.1083/jcb.109.3.1047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.109.3.1047</ArticleId><ArticleId IdType="pmc">PMC2115763</ArticleId><ArticleId IdType="pubmed">2670954</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummins P.M. Occludin: One Protein, Many Forms. Mol. Cell. Biol. 2012;32:242–250. doi: 10.1128/mcb.06029-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.06029-11</ArticleId><ArticleId IdType="pmc">PMC3255790</ArticleId><ArticleId IdType="pubmed">22083955</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirasago Y., Shimizu Y., Tanida I., Suzuki T., Suzuki R., Sugiyama K., Wakita T., Hanada K., Yagi K., Kondoh M., Fukasawa M. Occludin-Knockout Human Hepatic Huh7.5.1-8-Derived Cells Are Completely Resistant to Hepatitis C Virus Infection. Biol. Pharm. Bull. 2016;39:839–848.</Citation><ArticleIdList><ArticleId IdType="pubmed">26887345</ArticleId></ArticleIdList></Reference><Reference><Citation>Zihni C., Balda M.S., Matter K. Signalling at tight junctions during epithelial differentiation and microbial pathogenesis. J. Cell Sci. 2014;127:3401–3413. doi: 10.1242/jcs.145029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.145029</ArticleId><ArticleId IdType="pubmed">25125573</ArticleId></ArticleIdList></Reference><Reference><Citation>González-Mariscal L., Domínguez-Calderón A., Raya-Sandino A., Ortega-Olvera J.M., Vargas-Sierra O., Martínez-Revollar G. Tight junctions and the regulation of gene expression. Semin. Cell Dev. Biol. 2014;36:213–223. doi: 10.1016/j.semcdb.2014.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2014.08.009</ArticleId><ArticleId IdType="pubmed">25152334</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Flores J.M., Arias C.F. Tight junctions go viral. Viruses. 2015;7:5145–5154. doi: 10.3390/v7092865.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7092865</ArticleId><ArticleId IdType="pmc">PMC4584309</ArticleId><ArticleId IdType="pubmed">26404354</ArticleId></ArticleIdList></Reference><Reference><Citation>Baer A., Kehn-Hall K. Viral concentration determination through plaque assays: Using traditional and novel overlay systems. J. Vis. Exp. 2014;1:e52065. doi: 10.3791/52065.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/52065</ArticleId><ArticleId IdType="pmc">PMC4255882</ArticleId><ArticleId IdType="pubmed">25407402</ArticleId></ArticleIdList></Reference><Reference><Citation>Paradis T., Bègue H., Basmaciyan L., Dalle F., Bon F. Tight junctions as a key for pathogens invasion in intestinal epithelial cells. Int. J. Mol. Sci. 2021;22:1–21. doi: 10.3390/ijms22052506.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052506</ArticleId><ArticleId IdType="pmc">PMC7958858</ArticleId><ArticleId IdType="pubmed">33801524</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedicto I., Molina-Jiménez F., Bartosch B., Cosset F.-L., Lavillette D., Prieto J., Moreno-Otero R., Valenzuela-Fernández A., Aldabe R., López-Cabrera M., Majano P.L. The Tight Junction-Associated Protein Occludin Is Required for a Postbinding Step in Hepatitis C Virus Entry and Infection. J. Virol. 2009;83:8012–8020. doi: 10.1128/JVI.00038-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00038-09</ArticleId><ArticleId IdType="pmc">PMC2715771</ArticleId><ArticleId IdType="pubmed">19515778</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne C.B., Shen L., Turner J.R., Bergelson J.M. Coxsackievirus Entry across Epithelial Tight Junctions Requires Occludin and the Small GTPases Rab34 and Rab5. Cell Host Microbe. 2007;2:181–192. doi: 10.1016/j.chom.2007.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2007.07.003</ArticleId><ArticleId IdType="pmc">PMC2719558</ArticleId><ArticleId IdType="pubmed">18005733</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo X., Guo L., Zhang J., Xu Y., Gu W., Feng L., Wang Y. Tight Junction Protein Occludin Is a Porcine Epidemic Diarrhea Virus Entry Factor. J. Virol. 2017;91:e00202-17–e00214. doi: 10.1128/jvi.00202-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00202-17</ArticleId><ArticleId IdType="pmc">PMC5411586</ArticleId><ArticleId IdType="pubmed">28275187</ArticleId></ArticleIdList></Reference><Reference><Citation>Briceño M.P., Nascimento L.A.C., Nogueira N.P., Barenco P.V.C., Ferro E.A.V., Rezende-Oliveira K., Goulart L.R., Barbosa B.d.F., Alves P.T., Lima W.R., Silva N.M. Toxoplasma gondii Infection Promotes Epithelial Barrier Dysfunction of Caco-2 Cells. J. Histochem. Cytochem. 2016;64:459–469. doi: 10.1369/0022155416656349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1369/0022155416656349</ArticleId><ArticleId IdType="pmc">PMC4971781</ArticleId><ArticleId IdType="pubmed">27370796</ArticleId></ArticleIdList></Reference><Reference><Citation>Okai K., Ichikawa-Tomikawa N., Saito A.C., Watabe T., Sugimoto K., Fujita D., Ono C., Fukuhara T., Matsuura Y., Ohira H., Chiba H. A novel occludin-targeting monoclonal antibody prevents hepatitis C virus infection in vitro. Oncotarget. 2018;9:16588–16598. doi: 10.18632/oncotarget.24742.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.24742</ArticleId><ArticleId IdType="pmc">PMC5908272</ArticleId><ArticleId IdType="pubmed">29682171</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu Y., Shirasago Y., Kondoh M., Suzuki T., Wakita T., Hanada K., Yagi K. crossm Monoclonal Antibodies against Occludin Completely. 2018;92:1–19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5874423</ArticleId><ArticleId IdType="pubmed">29437969</ArticleId></ArticleIdList></Reference><Reference><Citation>Short K.R., Kasper J., Van Der Aa S., Andeweg A.C., Zaaraoui-Boutahar F., Goeijenbier M., Richard M., Herold S., Becker C., Scott D.P., et al. Influenza virus damages the alveolar barrier by disrupting epithelial cell tight junctions. Eur. Respir. J. 2016;47:954–966. doi: 10.1183/13993003.01282-2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01282-2015</ArticleId><ArticleId IdType="pubmed">26743480</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Waeckerlin R., Urbanowski M.D., van Marle G., Hobman T.C. West nile virus infection causes endocytosis of a specific subset of tight junction membrane proteins. PLoS One. 2012;7:378866–e37911. doi: 10.1371/journal.pone.0037886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0037886</ArticleId><ArticleId IdType="pmc">PMC3359987</ArticleId><ArticleId IdType="pubmed">22655077</ArticleId></ArticleIdList></Reference><Reference><Citation>Beau I., Cotte-Laffitte J., Amsellem R., Servin A.L. A Protein Kinase A-Dependent Mechanism by Which Rotavirus Affects the Distribution and mRNA Level of the Functional Tight Junction-Associated Protein, Occludin, in Human Differentiated Intestinal Caco-2 Cells. J. Virol. 2007;81:8579–8586. doi: 10.1128/jvi.00263-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00263-07</ArticleId><ArticleId IdType="pmc">PMC1951370</ArticleId><ArticleId IdType="pubmed">17553883</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda A., Iwasaki S., Watanabe T., Utsumi M., Watanabe Y. The mechanism selecting the guide strand from small RNA duplexes is different among Argonaute proteins. Plant Cell Physiol. 2008;49:493–500. doi: 10.1093/pcp/pcn043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pcp/pcn043</ArticleId><ArticleId IdType="pubmed">18344228</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y.E., Steitz J.A. Virus Meets Host MicroRNA: the Destroyer, the Booster, the Hijacker. Mol. Cell. Biol. 2014;34:3780–3787. doi: 10.1128/mcb.00871-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.00871-14</ArticleId><ArticleId IdType="pmc">PMC4187717</ArticleId><ArticleId IdType="pubmed">25047834</ArticleId></ArticleIdList></Reference><Reference><Citation>Dos Santos C.C., Amatullah H., Vaswani C.M., Maron-Gutierrez T., Kim M., Mei S.H.J., Szaszi K., Monteiro A.P.T., Varkouhi A.K., Herreroz R., et al. Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury. Eur. Respir. J. 2022;59 doi: 10.1183/13993003.04216-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.04216-2020</ArticleId><ArticleId IdType="pubmed">34112731</ArticleId></ArticleIdList></Reference><Reference><Citation>Makkoch J., Poomipak W., Saengchoowong S., Khongnomnan K., Praianantathavorn K., Jinato T., Poovorawan Y., Payungporn S. Human microRNAs profiling in response to influenza A viruses (subtypes pH1N1, H3N2, and H5N1) Exp. Biol. Med. 2016;241:409–420. doi: 10.1177/1535370215611764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1535370215611764</ArticleId><ArticleId IdType="pmc">PMC4935422</ArticleId><ArticleId IdType="pubmed">26518627</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Zhao C., Bamunuarachchi G., Wang Y., Liang Y., Huang C., Zhu Z., Xu D., Lin K., Senavirathna L.K., et al. miR-193b represses influenza A virus infection by inhibiting Wnt/β-catenin signalling. Cell. Microbiol. 2019;21:e13001–e13020. doi: 10.1111/cmi.13001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cmi.13001</ArticleId><ArticleId IdType="pmc">PMC6459727</ArticleId><ArticleId IdType="pubmed">30650225</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin C.H., Lee H., Kim H.R., Choi K.H., Joung J.G., Kim H.H. Regulation of PLK1 through competition between hnRNPK, miR-149-3p and miR-193b-5p. Cell Death Differ. 2017;24:1861–1871. doi: 10.1038/cdd.2017.106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2017.106</ArticleId><ArticleId IdType="pmc">PMC5635212</ArticleId><ArticleId IdType="pubmed">28708135</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore C., Parrish J.K., Jedlicka P. MiR-193b, downregulated in Ewing Sarcoma, targets the ErbB4 oncogene to inhibit anchorage-independent growth. PLoS One. 2017;12:01780288–e178112. doi: 10.1371/journal.pone.0178028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0178028</ArticleId><ArticleId IdType="pmc">PMC5436853</ArticleId><ArticleId IdType="pubmed">28542597</ArticleId></ArticleIdList></Reference><Reference><Citation>Meerson A., Traurig M., Ossowski V., Fleming J.M., Mullins M., Baier L.J. Human adipose microRNA-221 is upregulated in obesity and affects fat metabolism downstream of leptin and TNF-α. Diabetologia. 2013;56:1971–1979. doi: 10.1007/s00125-013-2950-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-013-2950-9</ArticleId><ArticleId IdType="pmc">PMC3737431</ArticleId><ArticleId IdType="pubmed">23756832</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulin J.A., Tommasi S., Elliot D., Hu D.G., Lewis B.C., Mangoni A.A. MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase. Sci. Rep. 2017;7:13996–14015. doi: 10.1038/s41598-017-14454-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-14454-1</ArticleId><ArticleId IdType="pmc">PMC5656623</ArticleId><ArticleId IdType="pubmed">29070803</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Luo J., Zhang H., Lu J. MicroRNAs in the Same Clusters Evolve to Coordinately Regulate Functionally Related Genes. Mol. Biol. Evol. 2016;33:2232–2247. doi: 10.1093/molbev/msw089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msw089</ArticleId><ArticleId IdType="pmc">PMC4989102</ArticleId><ArticleId IdType="pubmed">27189568</ArticleId></ArticleIdList></Reference><Reference><Citation>Artzi S., Kiezun A., Shomron N. miRNAminer: A tool for homologous microRNA gene search. BMC Bioinformatics. 2008;9:39–47. doi: 10.1186/1471-2105-9-39.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-9-39</ArticleId><ArticleId IdType="pmc">PMC2258288</ArticleId><ArticleId IdType="pubmed">18215311</ArticleId></ArticleIdList></Reference><Reference><Citation>Dos Santos, C. Mesenchymal Stromal (Stem) Cell (MSC) Therapy Modulates miR-193b-5p Expression to Attenuate Sepsis-Induced Acute Lung Injury.</Citation><ArticleIdList><ArticleId IdType="pubmed">36758998</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J., Chen Y., Liu G., Ren J., Go C., Ivanciuc T., Deepthi K., Casola A., Garofalo R.P., Bao X. Mitochondrial antiviral-signalling protein plays an essential role in host immunity against human metapneumovirus. J. Gen. Virol. 2015;96:2104–2113. doi: 10.1099/vir.0.000178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.000178</ArticleId><ArticleId IdType="pmc">PMC4681063</ArticleId><ArticleId IdType="pubmed">25953917</ArticleId></ArticleIdList></Reference><Reference><Citation>Heijink I.H., Brandenburg S.M., Noordhoek J.A., Postma D.S., Slebos D.J., Van Oosterhout A.J.M. Characterisation of cell adhesion in airway epithelial cell types using electric cell-substrate impedance sensing. Eur. Respir. J. 2010;35:894–903. doi: 10.1183/09031936.00065809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00065809</ArticleId><ArticleId IdType="pubmed">19741028</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao H., Ouyang H., Ip W., Du K., Duan W., Avolio J., Wu J., Duan C., Yeger H., Bear C.E., et al. Testing gene therapy vectors in human primary nasal epithelial cultures. Mol. Ther. Methods Clin. Dev. 2015;2 doi: 10.1038/mtm.2015.34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mtm.2015.34</ArticleId><ArticleId IdType="pmc">PMC4685663</ArticleId><ArticleId IdType="pubmed">26730394</ArticleId></ArticleIdList></Reference><Reference><Citation>Beasley, M.B. The Pathologist ’ S Approach to Acute Lung Injury. 719–727.</Citation><ArticleIdList><ArticleId IdType="pubmed">20441502</ArticleId></ArticleIdList></Reference><Reference><Citation>Burggraaf S., Bingham J., Payne J., Kimpton W.G., Lowenthal J.W., Bean A.G.D. Increased inducible nitric oxide synthase expression in organs is associated with a higher severity of H5N1 influenza virus infection. PLoS One. 2011;6:145611–e14612. doi: 10.1371/journal.pone.0014561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0014561</ArticleId><ArticleId IdType="pmc">PMC3023712</ArticleId><ArticleId IdType="pubmed">21283521</ArticleId></ArticleIdList></Reference><Reference><Citation>Forster S.C., Tate M.D., Hertzog P.J. MicroRNA as type I interferon-regulated transcripts and modulators of the innate immune response. Front. Immunol. 2015;6:334–339. doi: 10.3389/fimmu.2015.00334.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2015.00334</ArticleId><ArticleId IdType="pmc">PMC4495342</ArticleId><ArticleId IdType="pubmed">26217335</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruscella P., Bottini S., Baudesson C., Pawlotsky J.M., Feray C., Trabucchi M. Viruses and miRNAs: More friends than foes. Front. Microbiol. 2017;8:824–911. doi: 10.3389/fmicb.2017.00824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.00824</ArticleId><ArticleId IdType="pmc">PMC5430039</ArticleId><ArticleId IdType="pubmed">28555130</ArticleId></ArticleIdList></Reference><Reference><Citation>Fensterl V., Sen G.C. Interferon-Induced Ifit Proteins: Their Role in Viral Pathogenesis. J. Virol. 2015;89:2462–2468. doi: 10.1128/jvi.02744-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02744-14</ArticleId><ArticleId IdType="pmc">PMC4325746</ArticleId><ArticleId IdType="pubmed">25428874</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou Z., Sun Y., Rao Z. Current progress in antiviral strategies. Trends Pharmacol. Sci. 2014;35:86–102. doi: 10.1016/j.tips.2013.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2013.11.006</ArticleId><ArticleId IdType="pmc">PMC7112804</ArticleId><ArticleId IdType="pubmed">24439476</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullah H., Hou W., Dakshanamurthy S., Tang Q. Host targeted antiviral (HTA): Functional inhibitor compounds of scaffold protein RACK1 inhibit herpes simplex virus proliferation. Oncotarget. 2019;10:3209–3226. doi: 10.18632/oncotarget.26907.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.26907</ArticleId><ArticleId IdType="pmc">PMC6524932</ArticleId><ArticleId IdType="pubmed">31143369</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Zhang Z., Chang Z., Mao G., Hu S., Zeng A., Fu M. miR-193b-5p regulates chondrocytes metabolism by directly targeting histone deacetylase 7 in interleukin-1β-induced osteoarthritis. J. Cell. Biochem. 2019;120:12775–12784. doi: 10.1002/jcb.28545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.28545</ArticleId><ArticleId IdType="pubmed">30854734</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu S., Cao M., He Y., Zhang G., Liu Y., Du Y., Yang C., Gao F. CD44v6 targeted by miR-193b-5p in the coding region modulates the migration and invasion of breast cancer cells. J. Cancer. 2020;11:260–271. doi: 10.7150/jca.35067.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/jca.35067</ArticleId><ArticleId IdType="pmc">PMC6930394</ArticleId><ArticleId IdType="pubmed">31892992</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Zhang S., Yue M., Li Y., Bi J., Liu H. Angiotensin II inhibits apoptosis of mouse aortic smooth muscle cells through regulating the circNRG-1/miR-193b-5p/NRG-1 axis. Cell Death Dis. 2019;10:362. doi: 10.1038/s41419-019-1590-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1590-5</ArticleId><ArticleId IdType="pmc">PMC6494886</ArticleId><ArticleId IdType="pubmed">31043588</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond M.S., Farzan M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat. Rev. Immunol. 2013;13:46–57. doi: 10.1038/nri3344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3344</ArticleId><ArticleId IdType="pmc">PMC3773942</ArticleId><ArticleId IdType="pubmed">23237964</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto A.K., Williams G.D., Szretter K.J., White J.P., Proença-Módena J.L., Liu G., Olejnik J., Brien J.D., Ebihara H., Mühlberger E., et al. Human and Murine IFIT1 Proteins Do Not Restrict Infection of Negative-Sense RNA Viruses of the Orthomyxoviridae, Bunyaviridae, and Filoviridae Families. J. Virol. 2015;89:9465–9476. doi: 10.1128/jvi.00996-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00996-15</ArticleId><ArticleId IdType="pmc">PMC4542382</ArticleId><ArticleId IdType="pubmed">26157117</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng B., Zhao L., Wang W., Wang J., Wang H., Duan H., Zhang J., Qiao J. Investigation of antiviral state mediated by interferon-inducible transmembrane protein 1 induced by H9N2 virus and inactivated viral particle in human endothelial cells. Virol. J. 2017;14:213–312. doi: 10.1186/s12985-017-0875-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-017-0875-5</ArticleId><ArticleId IdType="pmc">PMC5670731</ArticleId><ArticleId IdType="pubmed">29100522</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Lam T.H., Soh M.K., Ye Z., Chen J., Ren E.C. Influenza A virus facilitates its infectivity by activating p53 to inhibit the expression of interferon-induced transmembrane proteins. Front. Immunol. 2018;9:1193. doi: 10.3389/fimmu.2018.01193.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01193</ArticleId><ArticleId IdType="pmc">PMC5990591</ArticleId><ArticleId IdType="pubmed">29904383</ArticleId></ArticleIdList></Reference><Reference><Citation>Fassati A. Fuse me IFITM can. Retrovirology. 2014;11:104–112. doi: 10.1186/s12977-014-0104-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12977-014-0104-x</ArticleId><ArticleId IdType="pmc">PMC4251678</ArticleId><ArticleId IdType="pubmed">25422110</ArticleId></ArticleIdList></Reference><Reference><Citation>Brass A.L., Huang I.C., Benita Y., John S.P., Krishnan M.N., Feeley E.M., Ryan B.J., Weyer J.L., van der Weyden L., Fikrig E., et al. The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus. Cell. 2009;139:1243–1254. doi: 10.1016/j.cell.2009.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.12.017</ArticleId><ArticleId IdType="pmc">PMC2824905</ArticleId><ArticleId IdType="pubmed">20064371</ArticleId></ArticleIdList></Reference><Reference><Citation>Feeley E.M., Sims J.S., John S.P., Chin C.R., Pertel T., Chen L.M., Gaiha G.D., Ryan B.J., Donis R.O., Elledge S.J., Brass A.L. IFITM3 inhibits influenza a virus infection by preventing cytosolic entry. Plos Pathog. 2011;7:e1002337. doi: 10.1371/journal.ppat.1002337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002337</ArticleId><ArticleId IdType="pmc">PMC3203188</ArticleId><ArticleId IdType="pubmed">22046135</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi E., Oh J., Kang H.R., Song M.J., Park S.H. BST2 inhibits infection of influenza A virus by promoting apoptosis of infected cells. Biochem. Biophys. Res. Commun. 2019;509:414–420. doi: 10.1016/j.bbrc.2018.12.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2018.12.110</ArticleId><ArticleId IdType="pubmed">30594400</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu S., Yin L., Mei S., Li J., Xu F., Sun H., Liu X., Cen S., Liang C., Li A., Guo F. BST-2 restricts IAV release and is countered by the viral M2 protein. Biochem. J. 2017;474:715–730. doi: 10.1042/BCJ20160861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20160861</ArticleId><ArticleId IdType="pubmed">28087685</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangeat B., Cavagliotti L., Lehmann M., Gers-Huber G., Kaur I., Thomas Y., Kaiser L., Piguet V. Influenza virus partially counteracts restriction imposed by tetherin/BST-2. J. Biol. Chem. 2012;287:22015–22029. doi: 10.1074/jbc.M111.319996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.319996</ArticleId><ArticleId IdType="pmc">PMC3381161</ArticleId><ArticleId IdType="pubmed">22493439</ArticleId></ArticleIdList></Reference><Reference><Citation>Abolhassani H., Landegren N., Bastard P., Materna M., Modaresi M., Du L., Aranda-Guillén M., Sardh F., Zuo F., Zhang P., et al. Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome. J. Clin. Immunol. 2022;42:471–483. doi: 10.1007/s10875-022-01215-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-022-01215-7</ArticleId><ArticleId IdType="pmc">PMC8798309</ArticleId><ArticleId IdType="pubmed">35091979</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavelin S., Hashimoto K., Malkinson J., Lazorova L., Toth I., Artursson P. A New Principle for Tight Junction Modulation Based on Occludin Peptides. Mol. Pharmacol. 2003;64:1530–1540. doi: 10.1124/mol.64.6.1530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.64.6.1530</ArticleId><ArticleId IdType="pubmed">14645684</ArticleId></ArticleIdList></Reference><Reference><Citation>Vietor I., Bader T., Paiha K., Huber L.A. Perturbation of the tight junction permeability barrier by occludin loop peptides activates β-catenin/TCF/LEF-mediated transcription. EMBO Rep. 2001;2:306–312. doi: 10.1093/embo-reports/kve066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/embo-reports/kve066</ArticleId><ArticleId IdType="pmc">PMC1083863</ArticleId><ArticleId IdType="pubmed">11306551</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirase T., Staddon J.M., Saitou M., Ando-Akatsuka Y., Itoh M., Furuse M., Fujimoto K., Tsukita S., Rubin L.L. Occludin as a possible determinant of tight junction permeability in endothelial cells. J. Cell Sci. 1997;110:1603–1613. doi: 10.1242/jcs.110.14.1603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.110.14.1603</ArticleId><ArticleId IdType="pubmed">9247194</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy K.M., Skare I.B., Stankewich M.C., Furuse M., Tsukita S., Rogers R.A., Lynch R.D., Schneeberger E.E. Occludin is a functional component of the tight junction. J. Cell Sci. 1996;109:2287–2298. doi: 10.1242/jcs.109.9.2287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.109.9.2287</ArticleId><ArticleId IdType="pubmed">8886979</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath D. Membrane biology. Nature. 2005;438:577. doi: 10.1038/438577a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/438577a</ArticleId></ArticleIdList></Reference><Reference><Citation>Saitou M., Furuse M., Sasaki H., Schulzke J.D., Fromm M., Takano H., Noda T., Tsukita S. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol. Biol. Cell. 2000;11:4131–4142. doi: 10.1091/mbc.11.12.4131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.11.12.4131</ArticleId><ArticleId IdType="pmc">PMC15062</ArticleId><ArticleId IdType="pubmed">11102513</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanayasu-Toyoda T., Ishii-Watabe A., Kikuchi Y., Kitagawa H., Suzuki H., Tamura H., Tada M., Suzuki T., Mizuguchi H., Yamaguchi T. Occludin as a functional marker of vascular endothelial cells on tube-forming activity. J. Cell. Physiol. 2018;233:1700–1711. doi: 10.1002/jcp.26082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.26082</ArticleId><ArticleId IdType="pubmed">28681912</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu Y., Lam J.K.W., Leung S.W.S., Liang W. Delivery of RNAi therapeutics to the airways - From bench to bedside. Molecules. 2016;21:1249–1332. doi: 10.3390/molecules21091249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules21091249</ArticleId><ArticleId IdType="pmc">PMC6272875</ArticleId><ArticleId IdType="pubmed">27657028</ArticleId></ArticleIdList></Reference><Reference><Citation>Krützfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., Stoffel M. Silencing of microRNAs in vivo with “antagomirs. Nature. 2005;438:685–689. doi: 10.1038/nature04303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04303</ArticleId><ArticleId IdType="pubmed">16258535</ArticleId></ArticleIdList></Reference><Reference><Citation>Jopling C.L. Targeting microRNA-122 to treat hepatitis C virus infection. Viruses. 2010;2:1382–1393. doi: 10.3390/v2071382.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v2071382</ArticleId><ArticleId IdType="pmc">PMC3185717</ArticleId><ArticleId IdType="pubmed">21994685</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahamtan A., Teymoori-Rad M., Nakstad B., Salimi V. Anti-inflammatory MicroRNAs and their potential for inflammatory diseases treatment. Front. Immunol. 2018;9:1377–1414. doi: 10.3389/fimmu.2018.01377.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01377</ArticleId><ArticleId IdType="pmc">PMC6026627</ArticleId><ArticleId IdType="pubmed">29988529</ArticleId></ArticleIdList></Reference><Reference><Citation>Ektesabi A.M., Mori K., Tsoporis J.N., Vaswani C.M., Gupta S., Walsh C., Varkouhi A.K., Mei S.H.J., Stewart D.J., Liles W.C., et al. Mesenchymal Stem/Stromal Cells Increase Cardiac miR-187-3p Expression in a Polymicrobial Animal Model of Sepsis. Shock. 2021;56:133–141. doi: 10.1097/SHK.0000000000001701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000001701</ArticleId><ArticleId IdType="pmc">PMC8240645</ArticleId><ArticleId IdType="pubmed">33378320</ArticleId></ArticleIdList></Reference><Reference><Citation>Deiuliis J.A. MicroRNAs as regulators of metabolic disease: Pathophysiologic significance and emerging role as biomarkers and therapeutics. Int. J. Obes. 2016;40:88–101. doi: 10.1038/ijo.2015.170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ijo.2015.170</ArticleId><ArticleId IdType="pmc">PMC4722234</ArticleId><ArticleId IdType="pubmed">26311337</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulcha J.T., Wang Y., Ma H., Tai P.W.L., Gao G. Viral vector platforms within the gene therapy landscape. Signal Transduct. Target. Ther. 2021;6:53. doi: 10.1038/s41392-021-00487-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00487-6</ArticleId><ArticleId IdType="pmc">PMC7868676</ArticleId><ArticleId IdType="pubmed">33558455</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi J.J. RNAi as a treatment for HIV-1 infection. Biotechniques. 2006;40:25–29. doi: 10.2144/000112167.</Citation><ArticleIdList><ArticleId IdType="doi">10.2144/000112167</ArticleId><ArticleId IdType="pubmed">16629384</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullis P.R., Hope M.J. Lipid Nanoparticle Systems for Enabling Gene Therapies. Mol. Ther. 2017;25:1467–1475. doi: 10.1016/j.ymthe.2017.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2017.03.013</ArticleId><ArticleId IdType="pmc">PMC5498813</ArticleId><ArticleId IdType="pubmed">28412170</ArticleId></ArticleIdList></Reference><Reference><Citation>Idris A., Davis A., Supramaniam A., Acharya D., Kelly G., Tayyar Y., West N., Zhang P., McMillan C.L.D., Soemardy C., et al. A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19. Mol. Ther. 2021;29:2219–2226. doi: 10.1016/j.ymthe.2021.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2021.05.004</ArticleId><ArticleId IdType="pmc">PMC8118699</ArticleId><ArticleId IdType="pubmed">33992805</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolgin E. How COVID unlocked the power of mRNA. Nature. 2021;589:189–191.</Citation><ArticleIdList><ArticleId IdType="pubmed">33437061</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristen A.V., Ajroud-Driss S., Conceição I., Gorevic P., Kyriakides T., Obici L. Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis. Neurodegener. Dis. Manag. 2019;9:5–23. doi: 10.2217/nmt-2018-0033.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nmt-2018-0033</ArticleId><ArticleId IdType="pubmed">30480471</ArticleId></ArticleIdList></Reference><Reference><Citation>Buya A.B., Witika B.A., Bapolisi A.M., Mwila C., Mukubwa G.K., Memvanga P.B., Makoni P.A., Nkanga C.I. Application of lipid-based nanocarriers for antitubercular drug delivery: A review. Pharmaceutics. 2021;13 doi: 10.3390/pharmaceutics13122041.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics13122041</ArticleId><ArticleId IdType="pmc">PMC8708335</ArticleId><ArticleId IdType="pubmed">34959323</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosas-Taraco A.G., Higgins D.M., Sánchez-Campillo J., Lee E.J., Orme I.M., González-Juarrero M. Intrapulmonary delivery of XCL1-targeting small interfering RNA in mice chronically infected with Mycobacterium tuberculosis. Am. J. Respir. Cell Mol. Biol. 2009;41:136–145. doi: 10.1165/rcmb.2008-0363OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2008-0363OC</ArticleId><ArticleId IdType="pmc">PMC2715903</ArticleId><ArticleId IdType="pubmed">19097989</ArticleId></ArticleIdList></Reference><Reference><Citation>Younes N., Zhou L., Amatullah H., Mei S.H.J., Herrero R., Lorente J.A., Stewart D.J., Marsden P., Liles W.C., Hu P., Dos Santos C.C. Mesenchymal stromal/stem cells modulate response to experimental sepsis-induced lung injury via regulation of miR-27a- 5p in recipient mice. Thorax. 2020;75:556–567. doi: 10.1136/thoraxjnl-2019-213561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2019-213561</ArticleId><ArticleId IdType="pmc">PMC7361025</ArticleId><ArticleId IdType="pubmed">32546573</ArticleId></ArticleIdList></Reference><Reference><Citation>Feuermann Y., Kang K., Gavrilova O., Haetscher N., Jang S.J., Yoo K.H., Jiang C., Gonzalez F.J., Robinson G.W., Hennighausen L. MiR-193b and miR-365-1 are not required for the development and function of brown fat in the mouse. RNA Biol. 2013;10:1807–1814. doi: 10.4161/rna.27239.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/rna.27239</ArticleId><ArticleId IdType="pmc">PMC3917983</ArticleId><ArticleId IdType="pubmed">24356587</ArticleId></ArticleIdList></Reference><Reference><Citation>du Sert N.P., Hurst V., Ahluwalia A., Alam S., Avey M.T., Baker M., Browne W.J., Clark A., Cuthill I.C., Dirnagl U., et al. The arrive guidelines 2.0: Updated guidelines for reporting animal research. Plos Biol. 2020;18:1–12. doi: 10.1371/journal.pbio.3000410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3000410</ArticleId><ArticleId IdType="pmc">PMC7360023</ArticleId><ArticleId IdType="pubmed">32663219</ArticleId></ArticleIdList></Reference><Reference><Citation>Cottey R., Rowe C.A., Bender B.S. Influenza virus. Curr Protoc Immunol. 2001:19.11.15–19.11.18.</Citation><ArticleIdList><ArticleId IdType="pubmed">18432752</ArticleId></ArticleIdList></Reference><Reference><Citation>REED L.J., MUENCH H. A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT. Am. J. Epidemiol. 1938;27:493–497. doi: 10.7723/antiochreview.72.3.0546.</Citation><ArticleIdList><ArticleId IdType="doi">10.7723/antiochreview.72.3.0546</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S., Lee C.M., Wang J.F., Parodo J., Jia S.H., Hu J., Marshall J.C. Heat-shock protein-90 prolongs septic neutrophil survival by protecting c-Src kinase and caspase-8 from proteasomal degradation. J. Leukoc. Biol. 2018;103:933–944. doi: 10.1002/JLB.4A0816-354R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.4A0816-354R</ArticleId><ArticleId IdType="pubmed">29393970</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>